{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:32:13Z","timestamp":1732771933449,"version":"3.29.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2023Y9386"],"award-info":[{"award-number":["2023Y9386"]}]},{"name":"Provincial-level special subsidy funds for health in Fujian Province of China","award":["Fujian Finance Index (2020) 467"],"award-info":[{"award-number":["Fujian Finance Index (2020) 467"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10620-024-08702-4","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:12:33Z","timestamp":1730740353000},"page":"4373-4391","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Analyses of Genes of Pediatric Non-alcoholic Fatty Liver Disease Associated with Energy Metabolism"],"prefix":"10.1007","volume":"69","author":[{"given":"Yijun","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"8702_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Kumar M, Eslam M et al. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2020;5:167\u2013228.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"8702_CR2","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ijo.2010.106","volume":"34","author":"S Wiegand","year":"2010","unstructured":"Wiegand S, Keller KM, R\u00f6bl M et al. Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Int J Obes (Lond). 2010;34:1468\u20131474.","journal-title":"Int J Obes (Lond)."},{"key":"8702_CR3","first-page":"446","volume":"34","author":"X Zhou","year":"2013","unstructured":"Zhou X, Hou DQ, Duan JL et al. Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34:446\u2013450.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"8702_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam M, Alkhouri N, Vajro P et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6:864\u2013873.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"8702_CR5","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cgh.2018.05.023","volume":"17","author":"JP Mann","year":"2019","unstructured":"Mann JP, Tang GY, Nobili V, Armstrong MJ. Evaluations of lifestyle, dietary, and pharmacologic treatments for pediatric nonalcoholic fatty liver disease: a systematic review. Clin Gastroenterol Hepatol. 2019;17:1457-1476.e7.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8702_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/dom.14322","volume":"23","author":"B Cariou","year":"2021","unstructured":"Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review. Diabetes Obes Metab. 2021;23:1069\u20131083.","journal-title":"Diabetes Obes Metab."},{"key":"8702_CR7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3748\/wjg.v19.i8.1166","volume":"19","author":"M Basaranoglu","year":"2013","unstructured":"Basaranoglu M, Basaranoglu G, Sabuncu T, Sent\u00fcrk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013;19:1166\u20131172.","journal-title":"World J Gastroenterol."},{"key":"8702_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019;7:726\u2013736.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"8702_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep4.1940","volume":"6","author":"K Yao","year":"2022","unstructured":"Yao K, Tarabra E, Sia D et al. Transcriptomic profiling of a multiethnic pediatric NAFLD cohort reveals genes and pathways associated with disease. Hepatol Commun. 2022;6:1598\u20131610.","journal-title":"Hepatol Commun."},{"key":"8702_CR10","doi-asserted-by":"publisher","first-page":"D760","DOI":"10.1093\/nar\/gkl887","volume":"35","author":"T Barrett","year":"2007","unstructured":"Barrett T, Troup DB, Wilhite SE et al. NCBI GEO: mining tens of millions of expression profiles\u2013database and tools update. Nucleic Acids Res. 2007;35:D760\u2013D765.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics. 2007;23:1846\u20131847.","journal-title":"Bioinformatics."},{"key":"8702_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. 2016;54:1\u201330.","journal-title":"Curr Protoc Bioinform."},{"key":"8702_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u2013425.","journal-title":"Cell Syst."},{"key":"8702_CR14","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315\u20131316.","journal-title":"J Thorac Oncol."},{"key":"8702_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-0716-0301-7_11","volume":"2117","author":"G Yu","year":"2020","unstructured":"Yu G. Gene ontology semantic similarity analysis using GOSemSim. Methods Mol Biol. 2020;2117:207\u2013215.","journal-title":"Methods Mol Biol."},{"key":"8702_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u2013287.","journal-title":"OMICS."},{"key":"8702_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201315550.","journal-title":"Proc Natl Acad Sci USA."},{"key":"8702_CR20","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u2013D613.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR21","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504.","journal-title":"Genome Res."},{"key":"8702_CR22","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u2013D131.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR23","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v20: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92\u2013D97.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR24","doi-asserted-by":"publisher","first-page":"D43","DOI":"10.1093\/nar\/gkw965","volume":"45","author":"KR Zhou","year":"2017","unstructured":"Zhou KR, Liu S, Sun WJ et al. ChIPBase v20: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 2017;45:D43\u2013D50.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","volume":"18","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Liu W, Zhang HM et al. hTFtarget: a comprehensive database for regulations of human transcription factors and their targets. Genom Proteom Bioinform. 2020;18:120\u2013128.","journal-title":"Genom Proteom Bioinform."},{"key":"8702_CR26","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ et al. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res. 2021;49:D1138\u2013D1143.","journal-title":"Nucleic Acids Res."},{"key":"8702_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u2013457.","journal-title":"Nat Methods."},{"key":"8702_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u2013259.","journal-title":"Methods Mol Biol."},{"key":"8702_CR29","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11.","journal-title":"BMC Syst Biol."},{"key":"8702_CR30","doi-asserted-by":"publisher","DOI":"10.1098\/rspl.1895.0041","author":"K Pearson","year":"1985","unstructured":"Pearson K. VII note on regression and inheritance in the case of two parents. Proc Royal Soc Lond. 1985. https:\/\/doi.org\/10.1098\/rspl.1895.0041.","journal-title":"Proc Royal Soc Lond"},{"key":"8702_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155:629\u2013647.","journal-title":"Gastroenterology."},{"key":"8702_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u2013141.","journal-title":"Free Radic Biol Med."},{"key":"8702_CR33","doi-asserted-by":"publisher","first-page":"1335112","DOI":"10.3389\/fimmu.2024.1335112","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Cheng W, Hu P et al. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis. Front Immunol. 2024;15:1335112.","journal-title":"Front Immunol."},{"key":"8702_CR34","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/biom12081079","volume":"12","author":"C Zeng","year":"2022","unstructured":"Zeng C, Chen M. Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis. Biomolecules. 2022;12:1079.","journal-title":"Biomolecules."},{"key":"8702_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","volume":"5","author":"O Govaere","year":"2023","unstructured":"Govaere O, Hasoon M, Alexander L et al. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nat Metab. 2023;5:572\u2013578.","journal-title":"Nat Metab."},{"key":"8702_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/hep.32148","volume":"75","author":"J Duan","year":"2022","unstructured":"Duan J, Wang Z, Duan R et al. Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice. Hepatology. 2022;75:140\u2013153.","journal-title":"Hepatology."},{"key":"8702_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16:517\u2013530.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"8702_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41419-018-0321-7","volume":"9","author":"C Yan","year":"2018","unstructured":"Yan C, Li J, Feng S, Li Y, Tan L. Long noncoding RNA gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p. Cell Death Dis. 2018;9:289.","journal-title":"Cell Death Dis."},{"key":"8702_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.aohep.2019.03.007","volume":"18","author":"F Xie","year":"2019","unstructured":"Xie F, Dong J, Zhu Y et al. HIF1a inhibitor rescues acute-on-chronic liver failure. Ann Hepatol. 2019;18:757\u2013764.","journal-title":"Ann Hepatol."},{"key":"8702_CR40","doi-asserted-by":"publisher","first-page":"110727","DOI":"10.1016\/j.cellsig.2023.110727","volume":"108","author":"K Cheng","year":"2023","unstructured":"Cheng K, Liu S, Li C, Zhao Y, Wang Q. IGF2BP3\/HIF1A\/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming. Cell Signal. 2023;108:110727.","journal-title":"Cell Signal."},{"key":"8702_CR41","doi-asserted-by":"publisher","first-page":"54599","DOI":"10.1074\/jbc.M406753200","volume":"279","author":"J Ostrowski","year":"2004","unstructured":"Ostrowski J, Klimek-Tomczak K, Wyrwicz LS, Mikula M, Schullery DS, Bomsztyk K. Heterogeneous nuclear ribonucleoprotein K enhances insulin-induced expression of mitochondrial UCP2 protein. J Biol Chem. 2004;279:54599\u201354609.","journal-title":"J Biol Chem."},{"key":"8702_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1053\/meta.2001.21691","volume":"50","author":"S Katoh","year":"2001","unstructured":"Katoh S, Hata S, Matsushima M et al. Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy\u2013a randomized controlled trial. Metabolism. 2001;50:414\u2013417.","journal-title":"Metabolism."},{"key":"8702_CR43","doi-asserted-by":"publisher","first-page":"31542","DOI":"10.1038\/srep31542","volume":"6","author":"P Mulder","year":"2016","unstructured":"Mulder P, Morrison MC, Verschuren L et al. Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice. Sci Rep. 2016;6:31542.","journal-title":"Sci Rep."},{"key":"8702_CR44","doi-asserted-by":"publisher","first-page":"1111430","DOI":"10.3389\/fendo.2023.1111430","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Du H, Zhao Y et al. Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: a meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023;14:1111430.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"8702_CR45","doi-asserted-by":"publisher","first-page":"2936236","DOI":"10.1155\/2023\/2936236","volume":"2023","author":"C Liang","year":"2023","unstructured":"Liang C, Xing H, Wang C, Xu X, Hao Y, Qiu B. Resveratrol improves the progression of osteoarthritis by regulating the SIRT1-FoxO1 pathway-mediated cholesterol metabolism. Mediators Inflamm. 2023;2023:2936236.","journal-title":"Mediators Inflamm."},{"key":"8702_CR46","doi-asserted-by":"publisher","first-page":"104808","DOI":"10.1016\/j.tiv.2020.104808","volume":"65","author":"G Luo","year":"2020","unstructured":"Luo G, Xiao L, Wang D et al. Resveratrol protects against ethanol-induced impairment of insulin secretion in INS-1 cells through SIRT1-UCP2 axis. Toxicol Vitro. 2020;65:104808.","journal-title":"Toxicol Vitro."},{"key":"8702_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/foods12010094","volume":"12","author":"J Guo","year":"2022","unstructured":"Guo J, Wang P, Cui Y, Hu X, Chen F, Ma C. Alleviation effects of microbial metabolites from resveratrol on non-alcoholic fatty liver disease. Foods. 2022;12:94.","journal-title":"Foods."},{"key":"8702_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/dna.2022.0581","volume":"42","author":"S Yarahmadi","year":"2023","unstructured":"Yarahmadi S, Farahmandian N, Fadaei R et al. therapeutic potential of resveratrol and atorvastatin following high-fat diet uptake-induced nonalcoholic fatty liver disease by targeting genes involved in cholesterol metabolism and miR33. DNA Cell Biol. 2023;42:82\u201390.","journal-title":"DNA Cell Biol."},{"key":"8702_CR49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/antiox12061269","volume":"12","author":"NA Anastasopoulos","year":"2023","unstructured":"Anastasopoulos NA, Charchanti AV, Barbouti A et al. The role of oxidative stress and cellular senescence in the pathogenesis of metabolic associated fatty liver disease and related hepatocellular carcinoma. Antioxidants (Basel). 2023;12:1269.","journal-title":"Antioxidants (Basel)."},{"key":"8702_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.014","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhu S, Jia Y et al. Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease. bioRxiv. 2023. https:\/\/doi.org\/10.1016\/j.cell.2023.03.014.","journal-title":"bioRxiv"},{"key":"8702_CR51","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/HYPERTENSIONAHA.116.07653","volume":"69","author":"JD Savant","year":"2017","unstructured":"Savant JD, Betoko A, Meyers KE et al. Vascular stiffness in children with chronic kidney disease. Hypertension. 2017;69:863\u2013869.","journal-title":"Hypertension."},{"key":"8702_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14292","author":"L Bao","year":"2023","unstructured":"Bao L, Hao P, Jiang M, Chu W. Liquiritigenin regulates insulin sensitivity and ameliorates inflammatory responses in the nonalcoholic fatty liver by activation PI3K\/AKT pathway. Chem Biol Drug Des. 2023. https:\/\/doi.org\/10.1111\/cbdd.14292.","journal-title":"Chem Biol Drug Des."},{"key":"8702_CR53","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/ptr.6417","volume":"33","author":"S Wang","year":"2019","unstructured":"Wang S, Yang FJ, Shang LC, Zhang YH, Zhou Y, Shi XL. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1\/PI3K\/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytother Res. 2019;33:2347\u20132359.","journal-title":"Phytother Res."},{"key":"8702_CR54","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-061021-030223","author":"MH Spooner","year":"2023","unstructured":"Spooner MH, Jump DB. Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use. Annu Rev Nutr. 2023. https:\/\/doi.org\/10.1146\/annurev-nutr-061021-030223.","journal-title":"Annu Rev Nutr."},{"key":"8702_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1440-1681.13750","volume":"50","author":"V Musazadeh","year":"2023","unstructured":"Musazadeh V, Karimi A, Malekahmadi M, Ahrabi SS, Dehghan P. Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: an umbrella systematic review and meta-analysis. Clin Exp Pharmacol Physiol. 2023;50:327\u2013334.","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"8702_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/21623945.2021.1970341","volume":"10","author":"Y Song","year":"2021","unstructured":"Song Y, Zhang J, Wang H et al. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. Adipocyte. 2021;10:424\u2013434.","journal-title":"Adipocyte."},{"key":"8702_CR57","doi-asserted-by":"publisher","first-page":"1142296","DOI":"10.3389\/fcvm.2023.1142296","volume":"10","author":"S Mo","year":"2023","unstructured":"Mo S, Wang Y, Yuan X et al. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis. Front Cardiovasc Med. 2023;10:1142296.","journal-title":"Front Cardiovasc Med."},{"key":"8702_CR58","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.31713","volume":"74","author":"L Kennedy","year":"2021","unstructured":"Kennedy L, Meadows V, Sybenga A et al. Mast cells promote nonalcoholic fatty liver disease phenotypes and microvesicular steatosis in mice fed a western diet. Hepatology. 2021;74:164\u2013182.","journal-title":"Hepatology."},{"key":"8702_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5114\/pjp.2020.95414","volume":"71","author":"E Lewandowska","year":"2020","unstructured":"Lewandowska E, Wosiak A, Zieli\u0144ski A et al. Role of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease. Pol J Pathol. 2020;71:38\u201345.","journal-title":"Pol J Pathol."},{"key":"8702_CR60","doi-asserted-by":"publisher","first-page":"775","DOI":"10.21037\/atm-22-2742","volume":"10","author":"M Shi","year":"2022","unstructured":"Shi M, Zhou Z, Zhou Z et al. Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure. Ann Transl Med. 2022;10:775.","journal-title":"Ann Transl Med."},{"key":"8702_CR61","doi-asserted-by":"publisher","first-page":"7194826","DOI":"10.1155\/2022\/7194826","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang Y, Jiang D, Zhou L, Wang B. Clinical characteristics and potential mechanisms in patients with abnormal liver function indices and elevated serum IgG4. Can J Gastroenterol Hepatol. 2022;2022:7194826.","journal-title":"Can J Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08702-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08702-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08702-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:06:06Z","timestamp":1732730766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08702-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8702"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08702-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}